Immune Response Selects Name Zorcell For Autoimmune Disease Vaccine
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Immune Response has chosen Zorcell as the name for its T-cell receptor (TCR) peptide therapeutic vaccine for autoimmune diseases. The company submitted the name to the Patent and Trademark Office for an agent to treat psoriasis.